The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study

R-Bendamustine is an effective treatment for follicular lymphoma (FL). Previous large trials demonstrated the prognostic role of the molecular minimal residual disease (MRD) during the most frequently adopted chemotherapeutic regimens, but there are not yet conclusive data about the effect of combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Galimberti, Sara, Ciabatti, Elena, Ercolano, Giacomo, Grassi, Susanna, Guerrini, Francesca, Cecconi, Nadia, Rousseau, Martina, Cervetti, Giulia, Mazziotta, Francesco, Iovino, Lorenzo, Falzetti, Franca, Falcinelli, Flavio, Bosi, Alberto, Rigacci, Luigi, Kovalchuk, Sofia, Vallisa, Daniele, Macchia, Lucia, Ciancia, Eugenio, Petrini, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489595/
https://www.ncbi.nlm.nih.gov/pubmed/28706485
http://dx.doi.org/10.3389/fphar.2017.00413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489595/
https://www.ncbi.nlm.nih.gov/pubmed/28706485
http://dx.doi.org/10.3389/fphar.2017.00413

Ejemplares similares